News
Demand for Mounjaro cannot realistically be metType 2 diabetes medication Mounjaro is less than a week away from being ...
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.
Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...
FROM nausea to constipation and life-threatening pancreatitis, fat jabs come with a long list of possible side effects. But, ...
It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and ...
‘Ozempic babies’ is the latest term to join the growing list of unexpected side effects of weight loss jabs. Ozempic feet, ...
A phased rollout of Mounjaro is set to begin across the UK next week as GP surgeries issue an urgent warning to patients.
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
There’s a lot of stigma around Mounjaro and a recent study found that people think weight loss that’s brought on by weight ...
It's estimated that 1.5 million Brits are currently using weight loss injections. Now, more could be able to receive these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results